6:02 AM ET
8-K
Reverse Stock Split
Apimeds Pharmaceuticals US Reverse Stock Split
Apimeds Pharmaceuticals US, Inc. implemented a 1-for-10 reverse stock split of its common stock effective July 24, 2026. The split reduced the number of outstanding shares from approximately 15.1 million to 1.5 million and adjusted the par value to $0.001 per share. The company's common stock began trading on a split-adjusted basis on the NYSE American under the symbol 'APUS' at the market open.